Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

NCT05706909 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05706909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05706909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
February 8, 2023
Completion date
July 31, 2027
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, osteonecrosis